Clinical Trials Logo
  1. Home
  2. Neurofibromatosis
  3. NCT02435628

Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF

Neurofibromatosis Clinical Trial

Official title:
Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis

Clinical Trial Summary

This is a prospective study through the NF clinic at Massachusetts General Hospital that will examine the relationship between psychosocial factors, health literacy, and satisfaction with the medical visit in adults with NF1, NF2, and Schwannomatosis. A total of 89 participants will be enrolled in the study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02435628
Study type Observational
Source Massachusetts General Hospital
Contact
Status Completed
Phase N/A
Start date February 2015
Completion date September 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT00754780 - Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 Phase 2
Completed NCT00589784 - Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Phase 2
Recruiting NCT04463316 - GROWing Up With Rare GENEtic Syndromes
Completed NCT01673009 - Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Phase 2
Recruiting NCT00598351 - Natural History Study of Patients With Neurofibromatosis Type 2
Completed NCT02298270 - Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype N/A
Terminated NCT01402817 - Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas Phase 2
Completed NCT02101736 - Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults Phase 2
Completed NCT01633008 - Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain Early Phase 1
Terminated NCT04461886 - A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I Phase 3
Completed NCT01275586 - Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Early Phase 1
Active, not recruiting NCT01140360 - Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas Phase 1/Phase 2
Completed NCT02211768 - Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Phase 1
Completed NCT00508235 - Quality of Friendships in Children With Neurofibromatosis N/A
Completed NCT01639950 - Validating Pain Scales in Children and Young Adults